The leading clinically validated oocyte assessment tools, with the industry’s largest, most robust dataset of over 120k images

Solving a gap in patient care, providing standardized, objective and 100% repeatable insights

LARGEST OOCYTE DATASET
Our AI model leverages 120,000+ oocyte images from over 8 countries, and growing.
SEAMLESS WORKFLOWS
We directly integrate with all major laser cameras and time-lapse systems to fit both egg freezing and IVF-ICSI workflows.
VALIDATED OOCYTE INSIGHTS
Numerous validation studies have proven our model to be generalizable across a wide range of image capture devices, patient types and regions.
PATIENT-FRIENDLY REPORTS
Our reports are an invaluable tool for treatment planning.
HOW IT WORKS

Powerful new insights – with easy workflow integration

01. Connect
Integrate your microscope laser camera or time-lapse system to our platform for seamless image-syncing, with on-call onboarding assistance available as needed.
02. Capture
Quickly capture and upload 2D oocyte images via your microscope laser camera, or automatically import images via your time-lapse system integration.
03. Analyze
Let our validated AI tool instantly assess oocyte quality, leveraging our state-of-the-art Ensemble Model to maximize predictive power through a combination of learned image-based features and explainable clinical features.
04. Inform
Review and share intuitive reports with colleagues and patients to support counselling conversations, documentation, and cycle-planning.
Our Reports

From images of MII oocytes to a shareable,
informative report that’s easy to interpret

PG 1
PG 2
+
1. CLINIC BRANDING
Add your logo for brand recognition and consistency across patient communications.
+
2. Key report details
Easily access patient information (ID, date of birth, date of retrieval), clinic contact information, date of report and number of oocytes frozen or evaluated.
+
3. Assessment results
Blastocyst prediction
The likelihood that each oocyte evaluated will develop into a blastocyst, based on our prediction assessment and other relevant statistics, such as the effects of cryopreservation on oocyte quality.

Live-birth prediction
The probability of achieving a live birth from mature oocytes evaluated, based on our prediction assessment and statistical modelling and a general estimate of live birth for comparison (based only on age and number of oocytes frozen).
+
4. HIGH IMPACT IMAGES
Give patients the emotional value of seeing their eggs for the first time, while keeping a visual record of each oocyte for quality assurance.
+
5. EDUCATIONAL INFORMATION
Add comments on each egg to provide more context, and to reduce back-and-forth communications, build trust, and manage expectations.
EVIDENCE YOU CAN TRUST

A proven, reliable way to measure oocyte quality and predict fertilization, blastocyst development, and embryo quality

More accurate than human assessment
In two validation studies, ¹,² VIOLET™ outperformed all 50 senior embryologists from 15 different IVF clinics in predicting blastocyst development of mature oocytes with an average relative increased accuracy of 18%.
Consistent results
When presented with the same oocyte image later on, VIOLET™ demonstrated a 100% repeatability rate (versus 81.4% for embryologists).¹,²
Correlation with blastocyst development and embryo quality
Studies have shown statistically significant differences in blastocyst development between oocytes with the highest (7.5-10) and lowest (0-2.5) MAGENTA™ scores (52% vs. 19%; p< 0.001], and significant differences between the average MAGENTA™ scores assigned to oocytes that developed into low quality and high quality blastocysts [5.8 vs 6.3; p < 0.001].²

How we help:

Embryologists
DOCTORS
CLINICS
Enhancing embryologists’ toolkits
  • Consistently measure oocyte quality more accurately than the human eye—and with no additional risk to eggs
  • Seamlessly integrate AI technology into your laboratory workflows
  • Enhance documentation and create an insurance policy for your work
“Violet is a really helpful counselling tool for egg freezing. I know many reputable clinics internationally are now using it, too. It helps patients understand that this is not a guarantee, and possibly convinces them to consider doing more egg-freezing cycles.”
—Dr. Mike Hartman, Medical Director at Generation Fertility
Bolstering doctors’ patient-counselling
  • Gain a fuller picture of your patients’ reproductive health with oocyte scoring added alongside standard sperm and embryo grading
  • Meet your patients’ needs with shareable easy-to-interpret reports
  • Manage expectations and help patients make informed decisions about their treatment
“Violet is a really helpful counselling tool for egg freezing. I know many reputable clinics internationally are now using it, too. It helps patients understand that this is not a guarantee, and possibly convinces them to consider doing more egg-freezing cycles.”
—Dr. Mike Hartman, Medical Director at Generation Fertility
Enabling clinics to lead the industry
  • Attract new patients and increase retention with marketable in-demand technology
  • Streamline operations and reduce costs with improved assessments that are more accurate, consistent, and efficient
  • Generate additional revenue without the need to overhaul laboratory equipment or workflows
“Violet is a really helpful counselling tool for egg freezing. I know many reputable clinics internationally are now using it, too. It helps patients understand that this is not a guarantee, and possibly convinces them to consider doing more egg-freezing cycles.”
—Dr. Mike Hartman, Medical Director at Generation Fertility
“Violet is a really helpful counselling tool for egg freezing. I know many reputable clinics internationally are now using it, too. It helps patients understand that this is not a guarantee, and possibly convinces them to consider doing more egg-freezing cycles.”2
—Dr. Mike Hartman, Medical Director at Generation Fertility2
“Violet is a really helpful counselling tool for egg freezing. I know many reputable clinics internationally are now using it, too. It helps patients understand that this is not a guarantee, and possibly convinces them to consider doing more egg-freezing cycles.”3
—Dr. Mike Hartman, Medical Director at Generation Fertility
Ready for a demo?

Get in touch with us

    Your personal information will be used to respond to your request and will be governed by our Privacy Policy.

    Form was submitted!

    1. Nayot D., Meriano J., Casper R., Krivoi A. An oocyte assessment tool using machine learning; Predicting blastocyst development based on a single image of an oocyte. Oral Presentation - 36th Annual Meeting of ESHRE - Copenhagen 2020
    2. Campbell A., Nayot D., Krivoi A., Barrie A., Jordan K. et al. Independent assessment of an artificial intelligence-based image analysis tool to predict fertilisation and blastocyst utilisation potential of oocytes, and comparison with ten expert embryologists. Oral Presentation - Fertility Online 2021 Conference; British Society
    3. Fjeldstad J., Mercuri N., Meriano J., Krivoi A., Campbell A., Smith R., Berrisford K., Drezet C., Casper R., Nayot D. Non-invasive AI image analysis unlocks the secrets of oocyte quality and reproductive potential by assigning ‘Magenta’ scores from 2-dimenstional (2-D) microscope images. O-204. Oral Presentation – 38th Annual Meeting of ESHRE – Milan 2022.